On Tuesday 28th April 2026, Juan Pablo Tosar, Founder and CSO of B4-RNA, presented ReJOIN-seq at a seminar titled “Beyond vesicles: update and sensing of inflammatory extracellular RNAs“. The talk was delivered as part of the seminar series hosted by the Initiative for RNA Medicine.
This presentation marks a significant milestone for B4-RNA, as it also represented the first public disclosure of preliminary data from its pilot clinical studies in colorectal and lung cancer. These early findings highlight the potential of ReJOIN-seq to advance extracellular RNA research and its clinical applications.
Further updates and more detailed results will be shared in this news section in the coming weeks.
